http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
치료 후 기류제한이 호전된 만성폐쇄성폐질환 환자에서 폐용적의 변화
박훈표 ( Hun Pyo Park ),박순효 ( Soon Hyo Park ),이상원 ( Sang Won Lee ),서용우 ( Yong Woo Seo ),이정은 ( Jeong Eun Lee ),서창균 ( Chang Kyun Seo ),곽진호 ( Jin Ho Kwak ),전영준 ( Young June Jeon ),이미영 ( Mi Young Lee ),정인성 ( 대한결핵 및 호흡기학회 2004 Tuberculosis and Respiratory Diseases Vol.57 No.2
지역사회획득폐렴 환자의 중증도 평가에서 Procalcitonin 유용성
박훈표 ( Hun Pyo Park ),이정수 ( Jung Soo Lee ),장예수 ( Ye Su Jang ),김민수 ( Min Su Kim ) 대한결핵 및 호흡기학회 2009 Tuberculosis and Respiratory Diseases Vol.67 No.5
Background: Thus far, research studies on community-acquired pneumonia (CAP) have focused on its clinical severity. Recently, it has been determined that procalcitonin (PCT) level is correlated with severity of CAP. A retrospective study conducted at our hospital used risk predictability and PCT to determine whether or no PCT is useful in assessing the severity of CAP. Methods: This study covered 92 CAP cases that were admitted to the respiratory department at Changwon Fatima Hospital between July 1, 2008 and June 30, 2009. All enrolled subjects were measured for infection markers and risk predictability. Results: Based on hospital admission data, enrolled subjects had Pneumonia Severity Index (PSI) scores serving as risk predictors showed that both PCT and white blood cell (WBC) were statistically significant as infection markers (p=0.001, 0.037). Thus, this study used ROC curves in PSI for data analysis. As a result, it was determined that the area under curve (AUC) of PCT and WBC was 0.694 and 0.593 respectively, indicating that PCT has a higher test value for WBC, when PCT was higher than 0.745 ng/mL. In addition, it was found that PCT levels higher than 0.745 ng/mL had higher PSI scores than the group with PCT lower than 0.745 ng/mL (p=0.032). Conclusion: In order to predict risk of pneumonia cases admitted due to symptoms of CAP, it is important to consider PCT as well as PSI, and follow-up monitoring of PCT cases.
만성폐쇄성폐질환 환자의 호흡곤란 평가에서 우심실 박출계수의 의의
이정은 ( Jung Eun Lee ),민보람 ( Bo Ram Min ),박재석 ( Jae Seok Park ),박훈표 ( Hun Pyo Park ),전미정 ( Mi Jung Jun ),원경숙 ( Kyung Sook Won ),최원일 ( Won Il Choi ) 대한결핵 및 호흡기학회 2006 Tuberculosis and Respiratory Diseases Vol.60 No.6
배경: 만성폐쇄성폐질환 환자의 호흡곤란은 일반적으로 폐활량에 반비례하나 유사한 폐기능에서도 서로 다른 호흡곤란을 호소한다. 본 연구는 만성폐쇄성폐질환 환자에서 우심실박출계수와 호흡곤란의 정도와 연관관계가 있는지를 알아보고자 한다. 방법: 호흡곤란의 정도는 Medical Research Council (MRC) 호흡곤란척도로 분석하였고, MRC 4/5도인 중증군 24명과, MRC 2/3도인 중등증군 16명을 비교 분석하였다. 심전도게이트 일회통과법을 이용한 방사성동위원소 심조영술을 이용하여 우심실 박출계수를 구했으며, 안정시 동맥가스분석 및 폐기능검사를 시행하였다. 결과: 기저 폐기능에서 잔기량의 예측치 평균이(%) 중증군에서(210±87) 중등증군(160±27)에 비해 유의하게 증가되었으나(P<0.03), 폐활량 및 확산계수 등에서는 유의한 차이가 관찰되지 않았다. 우심실 박출계수(%)는 중증군에서(25±8) 중등증군(35±6)에 비해 유의하게 감소되었으나(P<0.001), 동맥혈가스는 두 군 사이에 유의한 차이가 관찰되지 않았다. 다중회귀분석을 통해 우심실 박출계수가 독립적으로 호흡곤란에 영향을 미치는 인자로 밝혀졌다. 결론: 만성폐쇄성폐질환에서 우심실 박출계수가 호흡곤란의 정도에 영향을 미치는 것으로 보인다. Background: Patients with COPD generally complain of very different degrees of dyspnea regardless of their pulmonary function. The study, we assessed the right ventricular ejection fraction in relation to dyspnea in COPD patient. Methods: The pulmonary function including the diffusion capacity was measured. The right ventricle ejection fraction (RVEF) was measured using a first-pass radionuclide scan by multigated acquisition (MUGA). Forty patients with chronic obstructive pulmonary disease (COPD) were stratified for dyspnea according to the Medical Research Council (MRC) scale. Moderate dyspnea and severe dyspnea is defined as MRC 2/3 (n=16) and MRC 4/5 (n=24) respectively. Results: The baseline pulmonary function tests including DLCO and the resting arterial blood gas were similar in the moderate and severe dyspnea group, with the exception of the residual volume (% predicted) (moderate 160±27, severe 210±87, p<0.03). The right ventricle ejection fraction was significantly (p<0.001) lower in the severe dyspnea group (25±8) than in the moderate group (35±6). The independent factor assessed by multiple logistic regression revealed only the severity of dyspnea to be significantly associated with RVEF (p<0.02). Conclusion: This study showed that the right ventricle ejection fraction would contributes to severity of dyspnea in patients with a similar pulmonary function (Tuberc Respir Dis 2006; 60: 631-637)
지역사회 획득 폐렴환자의 중증도 평가에서 혈청 코티졸의 유용성
김미영 ( Mi Young Kim ),김민수 ( Min Su Kim ),김은영 ( Eun Young Kim ),박훈표 ( Hun Pyo Park ),최익훈 ( Ik Hun Choi ),구소희 ( So Hee Gu ) 대한결핵 및 호흡기학회 2010 Tuberculosis and Respiratory Diseases Vol.69 No.6
Background: High cortisol levels are frequently observed in patients with severe infections are of prognostic value in sepsis. The aim of this study was to evaluate the clinical usefulness of serum cortisol in assessment for the severity of community-acquired pneumonia (CAP). Methods: This study analyzed the results of 52 CAP subjects admitted in Changwon Fatima Hospital between July 2008 to May 2010. Total serum cortisol, infection markers such as C-reactive protein (CRP), procalcitonin (PCT) and CURB (Confusion, Uremia, Respiratory rate, Blood pressure)-65 were examined retrospectively. Results: In clinically unstable subjects on admission day 4, baseline serum cortisol, CURB-65, and CRP were elevated significantly compared to those of stable subjects. Area under curve (AUC) of cortisol, CRP, and CURB-65 from ROC curves were 0.847, 0.783, and 0.724 respectively. In the subjects with serum cortisol ≥22.82 μg/dL, CRP, PCT, CURB-65 score, and mortality were significantly elevated. Conclusion: These findings suggest that measurement of serum cortisol in early stage may provide helpful information in the assessment of CAP severity.
중소기업의 기술협력에서 출연연의 차별적 특징에 관한 연구
전승표(Seung-pyo Jun),박훈(Hun Park),유재영(Yoo Jae Young) 한국기술혁신학회 2017 기술혁신학회지 Vol.20 No.3
최근 출연연과 중소기업의 기술협력에 대한 범정부적 요구가 증가하면서 출연연의 중소기업 기술혁신 지원에 대한 긍정적인 시각과 부정적인 시각이 공존하는 것은 사실이다. 비록 선행연구를 통해서 출연연의 중소기업 지원은 중소기업의 기술혁신 성과를 높이는 경향이 있다는 사실은 확인되었지만, 본 연구는 왜 중소기업의 기술협력 대상이 꼭 출연연이어야 하는가라는 측면에서는 의문을 던진다. 이런 질의에 답하기 위해서, 본 연구는 먼저 2007년부터 2014년까지 중소기업의 외부 기술협력 행태의 시간적 변화를 정성적으로 살펴보았다. 다음으로 중소기업 기술협력 대상의 여러 대안과 비교해서 출연연과 기술협력을 하는 중소기업의 특징은 차별점이 있는지 군집분석을 통해서 살펴보았다. 마지막으로 출연연과 기술협력을 진행하는 기업의 특징을 규명하고, 향후 행정 효율화 및 선진화라는 측면에서 출연연 기술협력이 유력한 기업을 찾는데 도움을 주기 위해서, 판별분석을 활용해 기술협력 유력기업 판별식을 찾았다. 연구결과에 따르면 첫째, 중소기업 외부 기술협력의 대안들과 비교해서 출연연은 최고 수준의 만족도를 보이는 등 대안들 중에서 경쟁력이 높은 것으로 나타났다. 중소기업을 위한 출연연 기술협력의 필요성은 확인할 수 있었다. 둘째, 중소기업들을 구분하는데 있어서 출연연 기술협력 여부는 큰 의미가 없었다. 다만 대상에 상관없이 기술협력을 수행하는 중소기업들이 구분되는 것으로 나타났다. 셋째, 출연연과 기술협력을 하는 중소기업은 이미 공동연구가 활발했고 정부지원제도 활용에 익숙한 특징이 있었다. 본 연구의 결과는 출연연을 활용한 국가 R&D 전략에 여러 가지 시사점을 제공하고 출연연의 중소기업 지원 정책과 관련된 행정의 효율화에 기여할 것으로 기대된다. Recently, there has been an increase in government-wide demand for technological cooperation between government funded research institutes (GFRIs) and small and medium-sized enterprises (SMEs), while there remain a tension between positive and negative views regarding the support given by GFRIs to encourage the technological innovation of SMEs. Although preceding studies have found that the support given by GFRIs to SMEs tends to have the effect of enhancing the technological innovation outcomes of SMEs, this study examines the question of why the agent that provides technological cooperation to SMEs should be limited to GFRIs. To answer this question, in this study, we first examined the qualitative changes in the external technological cooperation behavior of SMEs over time, from 2007 to 2014. Next, we performed cluster analysis to examine whether there were distinctive characteristics of SMEs that engage in technological cooperation with GFRIs, compared to the various other alternatives available as technological cooperation partners for SMEs. Lastly, to help us identify the characteristics of the companies that technologically cooperate with GFRIs and to facilitate the administrative or ractical effort to find companies that would be strong candidates for technological cooperation with GFRIs, we used discriminant analysis to define a discriminant formula for such companies likely to engage in technological cooperation. The results of this study were as follows. First, GFRIs were the most competitive -- as demonstrated by the highest level of satisfaction, etc. - compared to the other alternatives for external technological cooperation available to SMEs. This confirmed the necessity for GFRIs to provide technological cooperation to SMEs. Secondly, the issue of whether the small and medium-sized enterprise had engaged in technological cooperation specifically with GFRIs was found not to be a very significant factor in distinguishing these companies. It was found, however, that SMEs engaged in technological cooperation were distinctive, regardless of the type of institution involved in the technological cooperation. Thirdly, SMEs that were in technological cooperation with GFRIs had the characteristics of being already active in joint research and already familiar with utilizing the systems available for governmental support. The findings of this study offers various insights relevant to establishing national R&D strategies using GFRIs and improving the efficiency of policies and administrative practices intended to help GFRIs assist SMEs.